Cintas Corporation (NasdaqGS:CTAS) entered into a definitive agreement to acquire ZEE Medical Inc. from McKesson Corporation (NYSE:MCK) for approximately $130 million in cash on July 31, 2015. The consideration consists of cash of $120.6 million and contingent consideration subject to certain holdback provisions of $13.4 million. The transaction is expected to close on August 1, 2015. Morrison & Foerster, LLP acted as a legal advisor to MaKesson and D. Brock Denton, Robert E. Coletti, Edward E. Steiner, Julie T. Muething, Ross J. Bextermueller, Allison A. Westfall, Jonathan M. Hiltz, Lisa Wintersheimer Michel, Barrett P. Tullis, Kasey L. Bond, Jill A. Weller, J. Michael Hurst, Mark E. Sims, Pamela Morgan Hodge, and Antoinette L. Schindel of Keating, Muething & Klekamp, PLL acted as legal advisors to Cintas Corporation. William Blair & Company, L.L.C. acted as financial advisor for ZEE Medical.

Cintas Corporation (NasdaqGS:CTAS) completed the acquisition of ZEE Medical Inc. from McKesson Corporation (NYSE:MCK) on August 1, 2015.